亚太地区给药系统市场至 2027 年 - 按给药途径（经粘膜、口服、注射、局部、植入和眼部）进行区域分析和预测；分销渠道（医院药房、零售药房、网上药房）；和申请（家庭护理机构、医院和诊所等）以及国家/地区
No. of Pages: 261 | Report Code: TIPRE00007130 | Category: Life Sciences
No. of Pages: 261 | Report Code: TIPRE00007130 | Category: Life Sciences
亚太地区给药系统市场预计将从 2018 年的 212,012.7 百万美元增至 2027 年的 441,337.0 百万美元。该市场预计将以 8.6% 的复合年增长率增长2019-2027。
市场的增长是由快速技术等因素推动的糖尿病护理设备的进步和肥胖率的增加。但是，由于该地区笔针重复使用的增加，该市场的增长可能会放缓。
< p>肥胖是该地区所有国家的主要问题之一，也是最令人担忧的问题。目前，超过二分之一的成年人和近六分之一的儿童患有肥胖症。肥胖是影响全球所有年龄段和收入人群的主要问题之一。超重和肥胖是指体内脂肪异常或过多堆积，导致健康受损。据印度政府 MoHFW 称，印度的人口约为。 2015 年预计有 6000 万成年人患有糖尿病（占总人口的 7.8%），其中超过 3000 万未得到诊断或治疗。因此，出现并发症和过早死亡的风险不断增加。肥胖在该地区人口糖尿病发病率上升中发挥着重要作用。体力活动对于维持血糖水平很重要。缺乏锻炼和不健康饮食（例如高脂肪和高热量饮食）会增加患肥胖症和糖尿病、心血管疾病（CVD）、慢性呼吸道疾病和与饮食相关的癌症的风险。根据全国健康与营养调查数据，2015-2016年，2-19岁青少年肥胖率为18.5%。不同年龄组的发病率有所不同，并且随着年龄的增长，发病率不断上升。虽然总体肥胖率仍高于上一代人。
缺乏锻炼、不健康饮食以及肥胖人口的快速增长预计将增加该地区人群患糖尿病的易感性。
由于以下原因，中国预计将引领亚太地区市场医疗器械行业的技术进步以及对成人和老年人群慢性病诊断和治疗的日益关注。此外，国内企业的出现和产品批准数量的增加预计将支持中国给药系统市场的增长。因此，考虑到上述因素，在预测期内，该国市场的增长可能会在亚太地区贡献最大份额。
图表：亚太地区其他地区给药系统市场收入和 2027 年预测（百万美元）
亚太地区药物输送系统 –市场细分
按产品
通过
申请
按分销渠道
按地理位置
公司简介
Strategic insights for Asia Pacific Drug Delivery Systems involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 212,012.7 Million |
| Market Size by 2027 | US$ 441,337.0 Million |
| Global CAGR (2019 - 2027) | 8.6% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By 给药途径
|
| Regions and Countries Covered | 亚太地区
|
| Market leaders and key company profiles |
The regional scope of Asia Pacific Drug Delivery Systems refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies
The Asia Pacific Drug Delivery Systems Market is valued at US$ 212,012.7 Million in 2018, it is projected to reach US$ 441,337.0 Million by 2027.
As per our report Asia Pacific Drug Delivery Systems Market, the market size is valued at US$ 212,012.7 Million in 2018, projecting it to reach US$ 441,337.0 Million by 2027. This translates to a CAGR of approximately 8.6% during the forecast period.
The Asia Pacific Drug Delivery Systems Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Drug Delivery Systems Market report:
The Asia Pacific Drug Delivery Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Drug Delivery Systems Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Drug Delivery Systems Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Drug Delivery Systems Market
